Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

NCT01425294 · clinicaltrials.gov ↗
TERMINATED
Status
231
Enrollment
INDUSTRY
Sponsor class

Stopped The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The use mothod of 250mg per month in clinical practice is off-label.

Conditions

Sponsor

AstraZeneca